Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
Individualized therapy for metastatic renal cell carcinoma
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program | Journal for ImmunoTherapy of Cancer
Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions | Future Oncology
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma | NEJM
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications
Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? | Article
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma | NEJM
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial - The Lancet Oncology
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
JCM | Free Full-Text | Risk Stratification and Treatment Algorithm of Metastatic Renal Cell Carcinoma
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology
xmlinkhub
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma | NEJM
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
ASCO GU 2022: Updates on Clinical Trials in First-Line Metastatic Renal Cell Carcinoma Plus Novel Pathways and Endpoints
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram
